Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00
Provider: Wright Reports
$115.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Blom ASA's Board Announces Its Statement on Merckx AS' Mandatory Offer


Wednesday, 25 Sep 2013 04:00am EDT 

Blom ASA announced that the Board of Directors of the Company has evaluated the offer document published by Merckx AS in connection with the launched of Merckx' mandatory offer to purchase all shares in Blom not already owned by Merckx at a price of NOK 0.10 per share (the Offer). The Board communicated that it is of the opinion that the offer price reflects a fair value to the shareholders. The Board has, however, noted that the shares of Blom are as per September 25, 2013 trading at a higher price than NOK 0.10 at the Oslo Stock Exchange. To the extent that any investors are willing to pay above NOK 0.10 per share, the Board would recommend the shareholders to consider such option. 

Company Quote

12.0
-0.45 -3.61%
4:54am EST